Oaktree Acquisition Corp. III Life Sciences financial data

Symbol
OACC, OACCU, OACCW on Nasdaq
Location
Los Angeles, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147% %
Debt-to-equity -124% %

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) $225,579 USD -369%
Nonoperating Income (Expense) $2,192,321 USD
Net Income (Loss) Attributable to Parent $1,966,742 USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,328,841 USD
Assets, Current $1,480,874 USD
Assets $201,249,963 USD
Liabilities, Current $1,226,788 USD
Liabilities $8,245,536 USD
Retained Earnings (Accumulated Deficit) $6,765,200 USD
Stockholders' Equity Attributable to Parent $6,764,662 USD -29191%
Liabilities and Equity $201,249,963 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $75,561 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,328,841 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares
Additional Paid in Capital $0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares